Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Immunomedics issued U.S. patent for cardiovascular diagnostic

July 15, 1997

Radiosensitizing and tumor-imaging effects of KADTF

July 14, 1997

Progression of Epix Medical's diagnostic agent to phase II triggers milestone payment

July 11, 1997

Epix Medical and Dyax form alliance for the development of novel diagnostics

July 8, 1997

Vysis' TriGen approved in France

July 7, 1997

New immunoassay for DVT diagnosis

July 2, 1997

FDA approves Hemagen Diagnostics' test for primary biliary cirrhosis

June 27, 1997

Xytronyx receives FDA approval to market periodontal disease test

June 25, 1997

FDA clears American Biogenetic Sciences' fibrinogen test

June 19, 1997

DuPont Merck's breast imaging agent approved in the U.K.

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...